Amanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Board Meeting to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.

Registered & Corporate Office: AMANTA HEALTHCARE LIMITED 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad–380058, Gujarat, INDIA. Tel.: 079 – 67777600 Email: info@amanta.co.in Website: www.amanta.co.in CIN: L24139GJ1994PLC023944 Date: October 26, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street, Mumbai – 400 001. Bandra (E), Mumbai – 400 051. Scrip Code: 544502 Trading Symbol: AMANTA Dear Sir/Madam, Sub: Board Meeting Intimation pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We would like to inform you that a Meeting of Board of Directors of Amanta Healthcare Limited is scheduled to be held on Tuesday, November 3, 2026, inter-alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. Trading Window: In continuation to our earlier intimation dated September 24, 2026; this is to inform you that the trading window, which was closed from Thursday, October 1, 2026 in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended; will reopen on Friday, November 6, 2026. Request you to kindly take same on record. Thanking you, Yours faithfully, FOR, AMANTA HEALTHCARE LIMITED NIKHITA DINODIA COMPANY SECRETARY & COMPLIANCE OFFICER Factory: 876, N.H. No. 8, Hariyala, Kheda – 387411, Gujarat, India. Tel 2694287700 Fax 2694287720